Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vascular Malformations 1Neoplasms 1Esophageal Neoplasms 1Anastomotic Leak 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Bioseal × Clear all
NCT03847857 2025-06-12

Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)

Sun Yat-sen University

Phase 3 Active not recruiting
360 enrolled
Gastrointestinal

Esophageal Neoplasms, Anastomotic Leak

NCT03110783 2019-11-18

Bioseal Dural Sealing Study BIOS-14-001

Guangzhou Bioseal Biotechnology Co., Ltd.

Phase 3 Completed
200 enrolled

Neoplasms, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡